|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US6750325B1
(en)
|
1989-12-21 |
2004-06-15 |
Celltech R&D Limited |
CD3 specific recombinant antibody
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
JP2631767B2
(ja)
*
|
1990-07-19 |
1997-07-16 |
アメリカ合衆国 |
ウイルス性呼吸器系疾患の予防または治療のためのエーロゾル
|
|
US5994510A
(en)
*
|
1990-12-21 |
1999-11-30 |
Celltech Therapeutics Limited |
Recombinant antibodies specific for TNFα
|
|
CA2108147C
(en)
|
1991-04-10 |
2009-01-06 |
Angray Kang |
Heterodimeric receptor libraries using phagemids
|
|
WO1994004679A1
(en)
*
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US6800738B1
(en)
|
1991-06-14 |
2004-10-05 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
DE122004000008I1
(de)
|
1991-06-14 |
2005-06-09 |
Genentech Inc |
Humanisierter Heregulin Antikörper.
|
|
US5824307A
(en)
*
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
|
US5646253A
(en)
*
|
1994-03-08 |
1997-07-08 |
Memorial Sloan-Kettering Cancer Center |
Recombinant human anti-LK26 antibodies
|
|
GB9207479D0
(en)
*
|
1992-04-06 |
1992-05-20 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
|
|
CA2144043C
(en)
*
|
1992-09-16 |
2005-01-18 |
Dennis R. Burton |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
|
US6685942B1
(en)
|
1993-12-10 |
2004-02-03 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
|
WO1994016094A2
(en)
|
1993-01-12 |
1994-07-21 |
Biogen, Inc. |
Recombinant anti-vla4 antibody molecules
|
|
NZ269735A
(en)
*
|
1993-07-30 |
1998-01-26 |
Oravax Inc |
Monoclonal iga antibody against respiratory syncytial virus (rsv)
|
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
|
US6310185B1
(en)
*
|
1994-03-08 |
2001-10-30 |
Memorial Sloan Kettering Cancer Center |
Recombinant human anti-Lewis Y antibodies
|
|
WO1995031546A1
(en)
*
|
1994-04-28 |
1995-11-23 |
Scotgen Biopharmaceuticals, Inc. |
Recombinant human anti-varicella zoster virus antibodies
|
|
EP0853487B1
(en)
*
|
1995-09-18 |
2000-07-05 |
Intracel Corporation |
Neutralizing monoclonal antibodies to respiratory syncytial virus
|
|
EP0909277B2
(en)
|
1996-06-07 |
2008-12-24 |
Poniard Pharmaceuticals, Inc. |
Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
|
|
EP0970206B1
(en)
|
1997-01-27 |
2008-07-23 |
Ludwig Institute For Cancer Research |
Lage-1 tumor associated nucleic acids
|
|
ES2239801T3
(es)
|
1997-04-02 |
2005-10-01 |
The Brigham And Women's Hospital, Inc. |
Uso de un agente para disminuir el riesgo de enfermedad cardiovascular.
|
|
US6160099A
(en)
*
|
1998-11-24 |
2000-12-12 |
Jonak; Zdenka Ludmila |
Anti-human αv β3 and αv β5 antibodies
|
|
CA2360396A1
(en)
|
1998-12-30 |
2000-07-13 |
Andrew M. Scharenberg |
Characterization of a calcium channel family
|
|
US7166573B1
(en)
|
1999-05-28 |
2007-01-23 |
Ludwig Institute For Cancer Research |
Breast, gastric and prostate cancer associated antigens and uses therefor
|
|
JP2003527826A
(ja)
|
1999-06-30 |
2003-09-24 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
癌関連抗原およびその使用
|
|
WO2001017557A1
(en)
|
1999-09-03 |
2001-03-15 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
|
|
CA2386088A1
(en)
|
1999-10-19 |
2001-04-26 |
Ludwig Institute For Cancer Research |
Mage-a12 antigenic peptides and uses thereof
|
|
SI20976A
(sl)
*
|
1999-12-23 |
2003-02-28 |
Icn Pharmaceuticals, Inc. |
Sestavki in postopki za L-nukleozide, L-nukleotide in njihove analoge
|
|
SI1296714T1
(sl)
|
2000-06-22 |
2010-01-29 |
S For Entpr University Of Iowa |
Kombinacija CpG-ja in protiteles, usmerjenih proti CD19, CD20, CD22 ali CD40 za zdravljenje ali preprečevanje raka
|
|
DE10211088A1
(de)
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
WO2003094856A2
(en)
|
2002-05-09 |
2003-11-20 |
The Brigham And Women's Hospital, Inc. |
1l1rl-1 as a cardiovascular disease marker and therapeutic target
|
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
NZ570201A
(en)
|
2003-02-11 |
2011-03-31 |
Shire Human Genetic Therapies |
Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge)
|
|
EP3081214A3
(en)
|
2003-08-29 |
2016-11-16 |
The Brigham And Women's Hospital, Inc. |
Inhibitors of cellular necrosis
|
|
DE10341812A1
(de)
|
2003-09-10 |
2005-04-07 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
DE10344799A1
(de)
|
2003-09-26 |
2005-04-14 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
|
DE102004023187A1
(de)
|
2004-05-11 |
2005-12-01 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
CA2624601C
(en)
|
2004-10-06 |
2018-07-03 |
The Brigham And Women's Hospital, Inc. |
Relevance of achieved levels of markers of systemic inflammation following treatment
|
|
DE102005013846A1
(de)
|
2005-03-24 |
2006-10-05 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
|
EP1762575A1
(en)
|
2005-09-12 |
2007-03-14 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated antigens for diagnosis and therapy
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
EP1795596A1
(en)
|
2005-12-08 |
2007-06-13 |
Ganymed Pharmaceuticals AG |
Composition and methods for therapy and diagnosis of cancer
|
|
DE102005059242A1
(de)
|
2005-12-12 |
2007-06-14 |
Johannes Gutenberg-Universität Mainz, Vertreten Durch Den Präsidenten |
Molekulare Marker für eine Tumordiagnose und -therapie
|
|
CN101421411B
(zh)
|
2006-04-13 |
2015-06-03 |
中外制药株式会社 |
牛磺酸转运蛋白基因
|
|
EP1911851A1
(en)
|
2006-10-12 |
2008-04-16 |
Ganymed Pharmaceuticals AG |
Compositions and methods for therapy and diagnosis of cancer and cancer metastasis
|
|
EP2118141B1
(en)
|
2007-02-23 |
2014-07-30 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Monoclonal antibodies that neutralize anthrax toxins
|
|
JP5635260B2
(ja)
|
2007-03-15 |
2014-12-03 |
中外製薬株式会社 |
ポリペプチドの製造方法
|
|
KR101577839B1
(ko)
|
2007-08-07 |
2015-12-15 |
추가이 세이야쿠 가부시키가이샤 |
이종 단백질의 제조 방법
|
|
RU2486245C2
(ru)
|
2007-10-15 |
2013-06-27 |
Чугаи Сейяку Кабусики Кайся |
Способ получения клетки, способной продуцировать гетеропротеины с высоким выходом
|
|
EP2060583A1
(en)
|
2007-10-23 |
2009-05-20 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
|
BRPI0818764B1
(pt)
*
|
2007-10-24 |
2017-11-21 |
Chugai Seiyaku Kabushiki Kaisha |
Process of production of a polipeptídeo
|
|
EP2108701A1
(en)
|
2008-04-10 |
2009-10-14 |
Ganymed Pharmaceuticals AG |
Methods involving MS4A12 and agents targeting MS4A12 for therapy, diagnosis and testing
|
|
CA2731255C
(en)
*
|
2008-07-21 |
2018-06-05 |
David M. Goldenberg |
Structural variants of antibodies for improved therapeutic characteristics
|
|
KR20110128316A
(ko)
|
2009-02-20 |
2011-11-29 |
가니메드 파마슈티칼스 아게 |
암의 진단 및 치료를 위한 방법 및 조성물
|
|
EP2221375A1
(en)
|
2009-02-20 |
2010-08-25 |
Ganymed Pharmaceuticals AG |
Methods and compositions for diagnosis and treatment of cancer
|
|
EP2221063A1
(en)
|
2009-02-20 |
2010-08-25 |
Ganymed Pharmaceuticals AG |
Methods and compositions for diagnosis and treatment of cancer
|
|
JP5715050B2
(ja)
|
2009-04-22 |
2015-05-07 |
中外製薬株式会社 |
異種タンパク質を高生産する細胞の作製方法
|
|
EP2249159A1
(en)
|
2009-04-29 |
2010-11-10 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
|
NZ734307A
(en)
|
2009-11-11 |
2020-05-29 |
Ganymed Pharmaceuticals Ag |
Antibodies specific for claudin 6 (cldn6)
|
|
DK3202789T3
(da)
|
2010-04-16 |
2020-05-18 |
Biogen Ma Inc |
Anti-vla-4-antistoffer
|
|
WO2011133894A2
(en)
*
|
2010-04-23 |
2011-10-27 |
Purdue Research Foundation |
Protein drug formulations and packages
|
|
KR20190000385A
(ko)
|
2010-05-04 |
2019-01-02 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
섬유증의 검출 및 치료
|
|
EP2404936A1
(en)
|
2010-07-06 |
2012-01-11 |
Ganymed Pharmaceuticals AG |
Cancer therapy using CLDN6 target-directed antibodies in vivo
|
|
CN107011440B
(zh)
|
2011-05-13 |
2021-03-05 |
加尼梅德药物公司 |
用于治疗表达密蛋白6之癌症的抗体
|
|
US20140322723A1
(en)
|
2011-11-22 |
2014-10-30 |
President and Dellows of Harvard College |
Diabetes diagnosis through the detection of glycated proteins in urine
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
EP2968276A4
(en)
|
2013-03-15 |
2017-02-15 |
President and Fellows of Harvard College |
Hybrid necroptosis inhibitors
|
|
WO2015014376A1
(en)
|
2013-07-31 |
2015-02-05 |
Biontech Ag |
Diagnosis and therapy of cancer involving cancer stem cells
|
|
MX2016009653A
(es)
|
2014-01-24 |
2017-03-27 |
Henry M Jackson Found Advancement Military Medicine Inc |
Anticuerpos contra glicoproteina f de virus hendra y nipah.
|
|
WO2016062323A1
(en)
|
2014-10-20 |
2016-04-28 |
Biontech Ag |
Methods and compositions for diagnosis and treatment of cancer
|
|
JO3555B1
(ar)
|
2015-10-29 |
2020-07-05 |
Merck Sharp & Dohme |
جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
|
|
US10899829B2
(en)
|
2016-02-23 |
2021-01-26 |
Indiana University Research And Technology Corporation |
Emapii neutralizing antibody limits influenza A virus (IAV)-induced lung injury
|
|
EP3463482B1
(en)
|
2016-06-07 |
2021-10-06 |
The Brigham and Women's Hospital, Inc. |
Methods relating to t peripheral helper cells in autoantibody-associated conditions
|
|
CN117050176A
(zh)
|
2017-07-31 |
2023-11-14 |
豪夫迈·罗氏有限公司 |
基于三维结构的人源化方法
|
|
KR102848349B1
(ko)
|
2018-06-04 |
2025-08-21 |
바이오젠 엠에이 인코포레이티드 |
감소된 효과기 기능을 갖는 항-ｖｌａ-4 항체
|